CEDAR KNOLLS, N.J.,
Nov. 5, 2019 /PRNewswire/
-- MYOS RENS Technology Inc. ("MYOS" or "the Company")
(NASDAQ: MYOS), an advanced nutrition company and the owner of
Fortetropin®, the unique proprietary bioactive composition made
from fertilized egg yolks clinically proven to help build
lean muscle, announced the expansion of its animal health
business with the launch of "Veterinarian Strength Myos Canine
Muscle Formula®."
Sold exclusively through leading veterinary practices,
Veterinarian Strength Myos Canine Muscle Formula combines
Fortetropin with the branched-chain amino acids (BCAA) leucine,
isoleucine and valine, further boosting the beneficial effects of
muscle protein synthesis resulting in greater improvement of muscle
health in canines.
"Since the launch of Myos Canine Muscle Formula, we have been
overwhelmed with the response from the marketplace. Dog
owners and veterinarians alike have reached out to us with their
stories of incredible animal recoveries from injury or surgery, and
the overall increase in vitality in elder dogs consuming the
product," commented Joseph Mannello,
Chief Executive Officer of MYOS. "We felt that the next logical
step in expanding our animal health business would be to offer a
'next level' of Myos Canine sold only through veterinary
practices. This will provide veterinarians an exclusive product to
introduce in their practices, while furthering our reach in this
critical area of the marketplace. In addition, by combining BCAAs
to our already clinically proven Fortetropin, we believe
Veterinarian Strength Myos Canine Muscle Formula will provide
greater benefit in improving overall muscle health in canines."
Clinical research conducted at Kansas State University College of Veterinary Medicine,
showed that Fortetropin, the key ingredient in Veterinarian
Strength Myos Canine Muscle Formula, significantly improved
recovery from injury and surgery and minimized disuse atrophy.
The product has been especially beneficial to aging dogs to improve
their mobility, vitality and quality of life. An additional
clinical study is being conducted at Kansas State University College of Veterinary Medicine to
evaluate the impact of Fortetropin on quality of life and activity
in geriatric dogs. For more information, please visit
www.myospet.com
Veterinarian Strength Myos Canine Muscle Formula will be
showcased at the New York Vet Show from November 7-8 at the Javits Center in Booth
#885. To register for the New York Vet Show, please visit
https://newyork.vetshow.com.
About MYOS RENS Technology Inc.
MYOS RENS
Technology Inc. (MYOS), "The Muscle Company", is a Cedar Knolls, NJ-based advanced nutrition
company that develops and markets products that improve muscle
health and performance. MYOS is the owner of Fortetropin, a
fertilized egg yolk-based product manufactured via a proprietary
process to retain and optimize its biological activity. Fortetropin
has been clinically shown to increase muscle size and lean body
mass in conjunction with resistance training. MYOS believes
Fortetropin has the potential to redefine existing standards of
physical health and wellness. For more information, please
visit www.myosrens.com.
About Myos Canine Muscle
Formula® Regular and
Veterinarian Strength®
Myos Canine
Muscle Formula is an advanced veterinary health supplement to
support muscle health in dogs, featuring
Fortetropin® as the active ingredient.
Fortetropin is made through a patented process that maintains the
vital nutrients of fertilized egg yolks to help build more lean
muscle and decrease muscle loss. Branched-chain amino acids
were added to Veterinarian Strength to further enhance muscle
recovery and rejuvenation in canines. For more information,
please visit www.myospet.com.
Forward-Looking Statements
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products,
including Qurr®,
Yolked®, MYOS Canine Muscle
Formula®, MYOS Canine Muscle Formula Veterinarian
Strength and MYOS Enteral
Nutrition Formula™, the success of our research and
development, the results of the clinical evaluation
of Fortetropin® and its
effects, the ability to enter into new partnership opportunities
and the success of our existing partnerships, the ability to
generate revenue and cash flow from sales of our products, the
ability to increase our revenue and gross profit margins, the
ability to achieve a sustainable, profitable business, the effect
of economic conditions, the ability to protect our intellectual
property rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in our filings with the Securities and Exchange
Commission. We undertake no obligation to update or revise any
forward-looking statement for events or circumstances after the
date on which such statement is made except as required by
law.
Investor Relations:
Porter LeVay & Rose
Matthew Abenante, IRC, SVP
Phone: 212-564-4700
Email: MYOS@plrinvest.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-rens-technology-launches-exclusive-veterinarian-strength-myos-canine-muscle-formula-300951171.html
SOURCE MYOS RENS Technology